Beijing Sun-Novo Pharmaceutical Research Co., Ltd. (SHA:688621)
China · Delayed Price · Currency is CNY 65.30
+0.34 (0.52%)
At close: Feb 27, 2026
SHA:688621 Market Cap
SHA:688621 has a market cap or net worth of 7.14 billion as of February 27, 2026. Its market cap has increased by 76.00% in one year.
Market Cap
7.14B
Enterprise Value
7.02B
Revenue
1.02B
Ranking
n/a
PE Ratio
54.14
Stock Price
65.30
Market Cap Chart
Since June 21, 2021, SHA:688621's market cap has decreased from 9.61B to 7.14B, a decrease of -25.72%. That is a compound annual growth rate of -6.15%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Feb 26, 2026 | 7.10B | 4.52% |
| Dec 31, 2025 | 6.79B | 60.85% |
| Dec 31, 2024 | 4.22B | -45.95% |
| Dec 29, 2023 | 7.81B | -4.64% |
| Dec 30, 2022 | 8.19B | -15.79% |
| Dec 31, 2021 | 9.73B | 1.26% |
| Jun 21, 2021 | 9.61B | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Heilongjiang ZBD Pharmaceutical | 7.76B |
| HARBIN GLORIA PHARMACEUTICALS Co., LTD | 7.75B |
| Hunan Jiudian Pharmaceutical | 7.69B |
| Jiuzhitang | 7.60B |
| Shandong Wit Dyne Health | 7.53B |
| Northeast Pharmaceutical Group | 7.42B |
| Shanghai Kaibao Pharmaceutical CO.,Ltd | 6.81B |
| Jiangsu Yahong Meditech | 6.71B |